國立虎尾科技大學 |

Point-of-Care Testing of COVID-19 = Current Status, Clinical Impact, and Future Therapeutic Perspectives /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Point-of-Care Testing of COVID-19/ by Abilash Gangula, Brandon Kim, Benjamin Casey, Allison Hamill, Hariharan Regunath, Anandhi Upendran.
Reminder of title:	Current Status, Clinical Impact, and Future Therapeutic Perspectives /
Author:	Gangula, Abilash.
other author:	Kim, Brandon.
Description:	VIII, 71 p. 13 illus., 11 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Biophysics. -
Online resource:	https://doi.org/10.1007/978-981-19-4957-9
ISBN:	9789811949579

Point-of-Care Testing of COVID-19 = Current Status, Clinical Impact, and Future Therapeutic Perspectives /
Gangula, Abilash.

Point-of-Care Testing of COVID-19Current Status, Clinical Impact, and Future Therapeutic Perspectives /[electronic resource] :by Abilash Gangula, Brandon Kim, Benjamin Casey, Allison Hamill, Hariharan Regunath, Anandhi Upendran. - 1st ed. 2022. - VIII, 71 p. 13 illus., 11 illus. in color.online resource. - Nanotheranostics,2197-6759. - Nanotheranostics,.

Introduction -- Methods -- Choice of clinical specimen for COVID-19 testing.

This book highlights the role of point-of-care (POC) testing in the effective management of the coronavirus disease 2019 (COVID-19) pandemic with an in-depth focus on the recent developments in the field, existing gaps, and future directions. POC tests are of utmost importance as they facilitate rapid and decentralized testing without much instrumentation and technical expertise. The book describes the current status of POC COVID-19 testing in three broad categories: Molecular, antigen, and antibody. The advantages, limitations, and adaption of each of the POC tests are reviewed while highlighting their clinical impact in real-world settings. The role of POC testing for COVID-19 screening, diagnosis, and surveillance has been emphasized. The subtle difference between POC and at-home tests is discussed while elaborating on the necessity for the latter for enhancing clinical impacts. A spotlight on the influence of variants on the performance of POC-COVID-19 tests is provided. The consideration of clinical implications of POC testing in hospitals with regards to improving therapeutic options, patient flow, enhancing the infection control measures, and early recruitment of patients into clinical trials is explained. Finally, the future perspectives that will aid the research community in the development of POC tests for COVID-19 or any infectious disease, in general, are presented. Overall, we believe this book can benefit the research community as it (i) presents a comprehensive understanding of current COVID-19 POC testing methods (ii) highlights features required to transform the current tests developed during the past year as POC diagnostics, and (iii) provides insights to address the unmet challenges in the field. .

ISBN: 9789811949579

Standard No.: 10.1007/978-981-19-4957-9doiSubjects--Topical Terms:

581576
Biophysics.

LC Class. No.: QH505

Dewey Class. No.: 571.4

Point-of-Care Testing of COVID-19 = Current Status, Clinical Impact, and Future Therapeutic Perspectives /
LDR:03330nam a22004095i 4500 001 1083881
003 DE-He213
005 20220930081845.0
007 cr nn 008mamaa
008 221228s2022 si | s |||| 0|eng d
020 $a 9789811949579 $9 978-981-19-4957-9
024 7 $a 10.1007/978-981-19-4957-9 $2 doi
035 $a 978-981-19-4957-9
050 4 $a QH505
050 4 $a QC176.8.N35
072 7 $a PHVN $2 bicssc
072 7 $a SCI009000 $2 bisacsh
072 7 $a PHVN $2 thema
082 0 4 $a 571.4 $2 23
100 1 $a Gangula, Abilash. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1390010
245 1 0 $a Point-of-Care Testing of COVID-19 $h [electronic resource] : $b Current Status, Clinical Impact, and Future Therapeutic Perspectives / $c by Abilash Gangula, Brandon Kim, Benjamin Casey, Allison Hamill, Hariharan Regunath, Anandhi Upendran.
250 $a 1st ed. 2022.
264 1 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2022.
300 $a VIII, 71 p. 13 illus., 11 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Nanotheranostics, $x 2197-6759
505 0 $a Introduction -- Methods -- Choice of clinical specimen for COVID-19 testing.
520 $a This book highlights the role of point-of-care (POC) testing in the effective management of the coronavirus disease 2019 (COVID-19) pandemic with an in-depth focus on the recent developments in the field, existing gaps, and future directions. POC tests are of utmost importance as they facilitate rapid and decentralized testing without much instrumentation and technical expertise. The book describes the current status of POC COVID-19 testing in three broad categories: Molecular, antigen, and antibody. The advantages, limitations, and adaption of each of the POC tests are reviewed while highlighting their clinical impact in real-world settings. The role of POC testing for COVID-19 screening, diagnosis, and surveillance has been emphasized. The subtle difference between POC and at-home tests is discussed while elaborating on the necessity for the latter for enhancing clinical impacts. A spotlight on the influence of variants on the performance of POC-COVID-19 tests is provided. The consideration of clinical implications of POC testing in hospitals with regards to improving therapeutic options, patient flow, enhancing the infection control measures, and early recruitment of patients into clinical trials is explained. Finally, the future perspectives that will aid the research community in the development of POC tests for COVID-19 or any infectious disease, in general, are presented. Overall, we believe this book can benefit the research community as it (i) presents a comprehensive understanding of current COVID-19 POC testing methods (ii) highlights features required to transform the current tests developed during the past year as POC diagnostics, and (iii) provides insights to address the unmet challenges in the field. .
650 0 $a Biophysics. $3 581576
650 0 $a Nanoscience. $3 632473
650 0 $a Therapeutics. $3 644915
650 0 $a Nanobiotechnology. $3 989992
650 0 $a Medicine, Preventive. $3 582813
650 0 $a Health promotion. $3 565089
650 1 4 $a Nanoscale Biophysics. $3 1388665
650 2 4 $a Health Promotion and Disease Prevention. $3 593964
700 1 $a Kim, Brandon. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1390011
700 1 $a Casey, Benjamin. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1390012
700 1 $a Hamill, Allison. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1390013
700 1 $a Regunath, Hariharan. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1390014
700 1 $a Upendran, Anandhi. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1390015
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811949562
776 0 8 $i Printed edition: $z 9789811949586
830 0 $a Nanotheranostics, $x 2197-6740 $3 1264911
856 4 0 $u https://doi.org/10.1007/978-981-19-4957-9
912 $a ZDB-2-PHA
912 $a ZDB-2-SXP
950 $a Physics and Astronomy (SpringerNature-11651)
950 $a Physics and Astronomy (R0) (SpringerNature-43715)